As of 2025-05-15, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is -0.09 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 CAD, the upside of Biovaxys Technology Corp is -369.86%.
Based on its market price of 0.04 CAD and our intrinsic valuation, Biovaxys Technology Corp (BIOV.CN) is overvalued by 369.86%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.09 - -0.09 | -0.09 | -369.86% |
| P/E | (0.00) - (0.00) | (0.00) | -102.7% |
| DDM - Stable | (0.37) - 19.62 | 9.62 | 27398.2% |
| DDM - Multi | (0.26) - 10.69 | (0.53) | -1619.6% |
| Market Cap (mil) | 10.27 |
| Beta | -0.23 |
| Outstanding shares (mil) | 293.43 |
| Enterprise Value (mil) | 10.18 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.74% |
| Cost of Debt | 5.00% |
| WACC | 5.73% |